KIF14 Promotes AKT Phosphorylation and Contributes to Chemoresistance in Triple-Negative Breast Cancer.
Singel SM, Cornelius C, Zaganjor E, Batten K, Sarode VR, Buckley DL, Peng Y, John GB, Li HC, Sadeghi N, Wright WE, Lum L, Corson TW, Shay JW Neoplasia 2014 Mar 16 3 247-256.e2
Cutaneous and mammary apocrine carcinomas have different immunoprofiles.
Piris A, Peng Y, Boussahmain C, Essary LR, Gudewicz TM, Hoang MP Hum. Pathol. 2014 Feb 45 2 320-6
Modulatory effect of neoadjuvant chemotherapy on biomarkers expression; assessment by digital image analysis and relationship to residual cancer burden in patients with invasive breast cancer.
Cockburn A, Yan J, Rahardja D, Euhus D, Peng Y, Fang Y, Rumnong Sarode V Hum. Pathol. 2014 Feb 45 2 249-58
Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes.
Daniel AR, Gaviglio AL, Knutson TP, Ostrander JH, D'Assoro AB, Ravindranathan P, Peng Y, Raj GV, Yee D, Lange CA Oncogene 2014 Jan
Ki-67 expression is increased in p16-expressing triple-negative breast carcinoma and correlates with p16 only in p53-negative tumors.
Sugianto J, Sarode V, Peng Y Hum. Pathol. 2013 Dec
Roles of p53 and p16 in Triple-negative Breast Cancer (This article was selected to be featured on Oncology Central.)
Dang D and Peng Y Breast Cancer Management (Future Medicine). 2013 2 6 537-544
Decreased Androgen Receptor Expression is Associated with Distant Metastases in Patients with Androgen Receptor Expressing Triple-negative Breast Carcinoma.
Sutton LM, Cao D, Sarode VR, Molberg KH, Torgbe K, Haley B and Peng Y. Am. J Clin. Pathol. 2012 138 511-516 (CME/SAM article)
Unusual Presentation of Multiple Fibroadenomas in Bilateral Breasts and Axillary Accessory Breast.
Zhang R, Bevan S, Sun P, Lu JZ and Peng Y. Breast Cancer: Basic and Clinical Research 2012 6 95-99
Potential prognostic tumor biomarkers in triple negative breast carcinoma. Journal of Peking University (Health Sciences).
Peng Y. 2012 44 735-741(English)
Presence of the sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
Kunkel J, Peng Y, Tao Y, Krigman H, and Cao D. Am. J Surg. Pathol. 2012 36(6) 831-7